Natixis’s UROPLASTY INC-NEW UPI Stock Holding History

Natixis’s Portfolio UPI Stock Details UPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-15,800	Closed	-$57K	–	573
2014 Q1	$57K	Hold	15,800	–	–	﹤0.01%	485
2013 Q4	$42K	Buy	+15,800	New	+$48.2K	﹤0.01%	547

Other funds holding UPI

Massachusetts Financial Services

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Rothschild Capital Partners New York $408M AUM 25.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Natixis's UPI Position: Q2 2014 in Review

Natixis sold out of UROPLASTY INC-NEW (UPI) in Q2 2014, closing a stake of 15,800 shares — an estimated $57K sold.

Natixis first reported a position in UPI in Q4 2013 and held it in 2 quarters. The position peaked at $57K in Q1 2014. 37 funds tracked by Wall St. Rank hold UPI as of Q2 2014.

Natixis reported no remaining UROPLASTY INC-NEW position as of Q2 2014 after selling out during the quarter.
Natixis sold 15,800 UROPLASTY INC-NEW shares in Q2 2014, an estimated $57K.
Natixis first reported a position in UROPLASTY INC-NEW in Q4 2013 and held it in 2 quarters.
Natixis's UROPLASTY INC-NEW position peaked at $57K in Q1 2014.
37 funds tracked by Wall St. Rank held UROPLASTY INC-NEW as of Q2 2014.

Based on Natixis's 13F filing for Q2 2014, filed 14 Aug 2014.